Management of Acute Hypertension in Wilms Tumor
The best approach to treat acute hypertension associated with Wilms tumor is to use intravenous labetalol or nicardipine as first-line agents, followed by oral antihypertensive therapy with calcium channel blockers and/or ACE inhibitors until tumor resection. 1, 2
Pathophysiology and Presentation
- Hypertension is a frequent complication of Wilms tumor, occurring in approximately 55% of patients at diagnosis 2
- The hypertension is primarily renin-mediated, with elevated plasma renin levels found in 81% of hypertensive Wilms tumor patients 2
- Hypertension is often severe but asymptomatic in children with Wilms tumor, with blood pressure typically elevated to 99th percentile + 30 mmHg 1
- Wilms tumor-associated hypertension typically affects young children under 2.5 years of age 1
Initial Management of Acute Hypertension
First-line Treatment
- For severe hypertension (≥180/110 mmHg with risk of acute organ damage), immediate intravenous antihypertensive therapy is indicated 3
- Intravenous labetalol or nicardipine are the preferred first-line agents for initial management 1
- Labetalol is particularly effective due to its combined alpha and beta-blocking properties, which helps control both peripheral resistance and heart rate 4
Cautions with IV Therapy
- Blood pressure reduction should be controlled and gradual, with a target of no more than 25% reduction in the first hour to avoid organ hypoperfusion 3, 5
- Careful monitoring is essential as rapid decreases in blood pressure can lead to cerebral, cardiac, or renal hypoperfusion 4
- Central venous and arterial pressure monitoring may be beneficial during the perioperative period 6
Transition to Oral Therapy
- After initial stabilization with IV agents, transition to oral antihypertensive medications is recommended 1
- Calcium channel blockers (such as nifedipine or amlodipine) are effective and commonly used as first-line oral agents 1
- ACE inhibitors (such as captopril) are particularly effective due to the renin-mediated nature of hypertension in Wilms tumor 2
- In resistant cases, combination therapy may be necessary, with dual therapy required in approximately 23% of cases 1
- For particularly resistant cases, a combination of ACE inhibitor and angiotensin receptor blocker (e.g., captopril and losartan) has been reported to be effective 7
Definitive Treatment
- The primary treatment for Wilms tumor-associated hypertension is surgical resection of the tumor 6
- Preoperative chemotherapy may be indicated based on tumor stage and may help reduce blood pressure before surgery 1
- Blood pressure typically normalizes after tumor resection, with most patients returning to normal blood pressure within one month of surgery 6
- The median duration of antihypertensive therapy is approximately 40 days (range: 9 to 195 days) 1
Long-term Considerations
- Long-term follow-up is important as Wilms tumor survivors have an increased risk of developing hypertension later in life 8
- Contributing factors to long-term hypertension risk include decreased nephron mass after nephrectomy, exposure to abdominal radiation, and nephrotoxic therapies 8
- Ambulatory blood pressure monitoring (ABPM) may be beneficial for detecting masked hypertension in Wilms tumor survivors 8
Treatment Algorithm
Acute phase (BP ≥180/110 mmHg):
Stabilization phase:
Definitive treatment:
Follow-up phase:
This approach effectively manages the acute hypertensive crisis while addressing the underlying cause, leading to resolution of hypertension in most patients following tumor resection.